Current status and progress of validation studies on the ICOPE scale: a scoping review
Frontiers in Public Health · 09.06.2026 · 14
DOI: 10.3389/fpubh.2026.1817233 ↗Kurz gefasst
Scoping Review in der Zeitschrift Frontiers in Public Health, online erschienen am 09.06.2026. Verfasst von Yuan Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Dali University, Dali, Yunnan, China. Hauptthemen laut MEDLINE: Geriatric Assessment, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
With the rapid global population aging, systematically and early identifying and managing functional decline in older adults has become a core challenge in public health. The Integrated Care for Older People (ICOPE) framework and its screening tool, proposed by the World Health Organization (WHO), aim to prevent disability by assessing intrinsic capacity. However, there is a lack of systematic review of the implementation strategies, effects, and challenges of this tool in different global contexts. This study aimed to review the global implementation evidence of the ICOPE screening tool, analyze its integration paths and influencing factors, and provide a basis for constructing an integrated care model suitable for different resource environments.
Methods
This study systematically retrieved and included literatures meeting the criteria, and comprehensively sorted and conducted comparative analyses of the design, population, positive screening rate, tool performance indicators (such as sensitivity and specificity), and implementation challenges of the included studies.
Results
The study demonstrated significant heterogeneity in the global application of the ICOPE screening tool. The positive screening rates vary greatly due to differences in research design, target populations, and assessment criteria. The psychometric properties of the tool differ across various cultural backgrounds, and the implementation process faces common challenges such as disconnection between screening and intervention, uneven accessibility of digital tools, lack of evidence for long-term effects, and absence of unified diagnostic criteria.
Conclusion
The ICOPE framework shows preliminary feasibility and global acceptance, but the performance of the screening tools needs to be interpreted in the context of specific cultures and populations. Future research should focus on unifying core measurement indicators, conducting long-term validity verification, and establishing a standardized implementation path integrating screening, assessment, and intervention to promote effective implementation of this strategy globally, especially in resource-limited areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatrics, Dali University, Dali, Yunnan, China.
- Department of Geriatrics, People's Hospital of Dali Prefecture, Dali, Yunnan, China.
- Department of Geriatrics, Affiliated Minzu Hospital, Hubei Minzu University, Enshi, Hubei, China.
- Department of Health Management, Haiyuan College, Kunming Medical University, Kunming, Yunnan, China.
Zitieren
APA
Zhao, Y., He, M., Zhao, S., Guo, L., Li, G., Tan, Y., Yang, J., Lan, B., & Su, Y. (2026). Current status and progress of validation studies on the ICOPE scale: a scoping review. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1817233
Vancouver
Zhao Y, He M, Zhao S, Guo L, Li G, Tan Y, et al. Current status and progress of validation studies on the ICOPE scale: a scoping review. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1817233
BibTeX
@article{Zhao2026,
author = {Zhao, Yuan and He, Mei and Zhao, Songye and Guo, Le and Li, Gan and Tan, Ying and Yang, Jinjiao and Lan, Binghua and Su, Yunpeng},
title = {Current status and progress of validation studies on the ICOPE scale: a scoping review},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1817233}
}
EUVIMED